Cyclooxygenase-2 inhibitors: a new therapeutic option in the treatment of macular edema after cataract surgery.
J Cataract Refract Surg
; 31(7): 1437-40, 2005 Jul.
Article
in En
| MEDLINE
| ID: mdl-16105620
ABSTRACT
Two patients had uneventful phacoemulsification. After initial improvement, vision deteriorated because of cystoid macular edema (CME). In 1 patient, treatment with systemic nonsteroidal antiinflammatory drugs showed significant improvement in visual acuity but had to be discontinued because of side effects and a relapse of the disease. In the other patient, this therapy was not sufficient. Both patients were given valdecoxib, a cyclooxygenase-2 inhibitor. The new therapy was tolerated well and led to significant and stable improvement in visual acuity in both patients. To our knowledge, this is the first report of using a cyclooxygenase-2 inhibitor in the treatment of clinically significant CME.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Postoperative Complications
/
Sulfonamides
/
Macular Edema
/
Cyclooxygenase Inhibitors
/
Phacoemulsification
/
Isoxazoles
Type of study:
Etiology_studies
Limits:
Aged
/
Female
/
Humans
Language:
En
Journal:
J Cataract Refract Surg
Journal subject:
OFTALMOLOGIA
Year:
2005
Type:
Article
Affiliation country:
Germany